- Home
- KRMD vs TEAF Comparison
KRMD vs TEAF Comparison
Compare KRMD & TEAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRMD
- TEAF
- Stock Information
- Founded
- KRMD 1980
- TEAF 2017
- Country
- KRMD United States
- TEAF United States
- Employees
- KRMD N/A
- TEAF N/A
- Industry
- KRMD Medical/Dental Instruments
- TEAF Trusts Except Educational Religious and Charitable
- Sector
- KRMD Health Care
- TEAF Finance
- Exchange
- KRMD Nasdaq
- TEAF Nasdaq
- Market Cap
- KRMD 187.5M
- TEAF 174.8M
- IPO Year
- KRMD N/A
- TEAF N/A
- Fundamental
- Price
- KRMD $4.74
- TEAF $12.20
- Analyst Decision
- KRMD Strong Buy
- TEAF
- Analyst Count
- KRMD 5
- TEAF 0
- Target Price
- KRMD $4.50
- TEAF N/A
- AVG Volume (30 Days)
- KRMD 157.7K
- TEAF 56.1K
- Earning Date
- KRMD 03-12-2025
- TEAF 01-01-0001
- Dividend Yield
- KRMD N/A
- TEAF 9.20%
- EPS Growth
- KRMD N/A
- TEAF N/A
- EPS
- KRMD N/A
- TEAF N/A
- Revenue
- KRMD $31,993,796.00
- TEAF N/A
- Revenue This Year
- KRMD $20.04
- TEAF N/A
- Revenue Next Year
- KRMD $14.15
- TEAF N/A
- P/E Ratio
- KRMD N/A
- TEAF N/A
- Revenue Growth
- KRMD 11.57
- TEAF N/A
- 52 Week Low
- KRMD $2.01
- TEAF $11.11
- 52 Week High
- KRMD $5.05
- TEAF $13.30
- Technical
- Relative Strength Index (RSI)
- KRMD 69.66
- TEAF 51.19
- Support Level
- KRMD $4.16
- TEAF $12.03
- Resistance Level
- KRMD $5.05
- TEAF $12.20
- Average True Range (ATR)
- KRMD 0.21
- TEAF 0.13
- MACD
- KRMD 0.04
- TEAF 0.01
- Stochastic Oscillator
- KRMD 72.94
- TEAF 37.78
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets, and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
About TEAF Ecofin Sustainable and Social Impact Term Fund
Tortoise Essential Assets Income Term is a US-based non-diversified, closed-end management investment company. Its investment objective is to provide common shareholders with a high level of total return with an emphasis on current distributions.